| Innohep 3,500 IU, solution for injection PA0046/060/009 |
Tinzaparin sodium |
Leo Laboratories Limited |
Marketed |
| Innohep 3,500 IU, solution for injection PPA1463/251/001 |
Tinzaparin sodium |
IMED Healthcare Ltd., |
— |
| innohep 4,500 IU, solution for injection PPA0465/499/001 |
Tinzaparin sodium |
PCO Manufacturing Ltd. |
— |
| Innohep 4,500 IU, solution for injection PA0046/060/007 |
Tinzaparin sodium |
Leo Laboratories Limited |
Marketed |
| Innohep 4,500 IU, solution for injection PPA1463/251/002 |
Tinzaparin sodium |
IMED Healthcare Ltd., |
— |
| Innohep 8,000 IU in 0.4 ml, Solution for injection PA0046/060/012 |
Tinzaparin sodium |
Leo Laboratories Limited |
Marketed |
| Innovace 10 mg tablets PA23198/005/003 |
Enalapril maleate |
Organon Pharma (Ireland) Limited |
Marketed |
| Innovace 10 mg tablets PPA0465/462/001 |
Enalapril maleate |
PCO Manufacturing Ltd. |
— |
| Innovace 10 mg tablets PPA1463/208/001 |
Enalapril maleate |
IMED Healthcare Ltd. |
— |
| Innovace 2.5 mg Tablets PA23198/005/001 |
Enalapril maleate |
Organon Pharma (Ireland) Limited |
Marketed |
| Innovace 20 mg tablets PA23198/005/004 |
Enalapril maleate |
Organon Pharma (Ireland) Limited |
Marketed |
| Innovace 20 mg tablets PPA1463/208/002 |
Enalapril maleate |
IMED Healthcare Ltd. |
— |
| Innovace 5 mg tablets PA23198/005/002 |
Enalapril maleate |
Organon Pharma (Ireland) Limited |
Marketed |
| Innozide 20 mg/12.5 mg Tablets PA23198/006/001 |
Enalapril maleate, Hydrochlorothiazide |
Organon Pharma (Ireland) Limited |
Not marketed |
| INOmax EU/1/01/194/001 |
Nitric oxide |
AGA AB |
— |
| INOmax 400 ppm mol/mol medicinal gas, compressed EU/1/01/194/003-004 |
Nitric oxide |
INO Therapeutics AB |
— |
| Inovelon EU/1/06/378/1-16 |
Rufinamide |
Eisai GmbH |
— |
| Inovelon 40 mg/ml oral suspension EU/1/06/378/017 |
Rufinamide |
Eisai GmbH |
— |
| INREBIC 100 mg hard capsules EU/1/20/1514/001 |
Fedratinib dihydrochloride monohydrate, Fedratinib |
Bristol-Myers Squibb Pharmaceuticals uc |
— |
| INSPRA DPR1328/016/002 |
Eplerenone |
B & S Healthcare |
— |
| INSPRA 25 mg film-coated tablets PA23355/052/001 |
Eplerenone |
Viatris Healthcare Limited |
Marketed |
| INSPRA 50 mg film-coated tablets PA23355/052/002 |
Eplerenone |
Viatris Healthcare Limited |
Marketed |
| Instanyl 100 microgram Nasal spray solution EU/1/09/531/014-017 |
FENTANYL CITRATE |
Istituto Gentili S.r.l. |
— |
| Instanyl 100 micrograms/dose nasal spray, solution EU/1/09/531/4-6 |
FENTANYL CITRATE |
Istituto Gentili S.r.l. |
— |
| Instanyl 200 microgram/dose Nasal spray solution EU/1/09/531/7-9 |
FENTANYL CITRATE |
Istituto Gentili S.r.l. |
— |
| Instanyl 200 micrograms nasal spray, solution EU/1/09/531/018-021 |
FENTANYL CITRATE |
Istituto Gentili S.r.l. |
— |
| Instanyl 50 microgram Nasal spray solution EU/1/09/531/010-013 |
FENTANYL CITRATE |
Istituto Gentili S.r.l. |
— |
| Instanyl 50 microgram/dose Nasal spray solution EU/1/09/531/1-3 |
FENTANYL CITRATE |
Istituto Gentili S.r.l. |
— |
| Instillagel 6 ml Urethral, vaginal, rectal and oropharyngeal gel PA0328/001/001 |
Chlorhexidine digluconate (as chlorhexidine digluconate solution (20% w/v) ph.eur., Methyl parahydroxybenzoate, Propyl parahydroxybenzoate, Lidocaine hydrochloride |
Farco-Pharma GmbH |
Marketed |
| Instillagel® 11 ml Urethral, vaginal, rectal and oropharyngeal gel PA0328/001/002 |
Chlorhexidine digluconate (as chlorhexidine digluconate solution (20% w/v) ph.eur., Methyl parahydroxybenzoate, Propyl parahydroxybenzoate, Lidocaine hydrochloride |
Farco-Pharma GmbH |
Marketed |
| Insulatard EU/1/02/233/1-15 |
Insulin human |
Novo Nordisk A/S |
— |
| Insulatard 100 international units/ml suspension for injection in vial EU/1/02/233/003-004 |
Insulin human |
Novo Nordisk A/S |
— |
| Insulatard FlexPen EU/1/02/233/013 |
Insulin human |
Novo Nordisk A/S |
— |
| Insulatard InnoLet EU/1/02/233/010-012 |
Insulin human |
Novo Nordisk A/S |
— |
| Insulatard Penfill EU/1/02/233/005-007 |
Insulin human |
Novo Nordisk A/S |
— |
| Insulin aspart Sanofi EU/1/20/1447/001-005 |
Insulin aspart |
Sanofi Winthrop Industrie |
— |
| Insulin aspart Sanofi EU/1/20/1447/001-007 |
Insulin aspart |
Sanofi Winthrop Industrie |
— |
| Insulin lispro Sanofi 100 units/ml solution for injection EU/1/17/1203/001-008 |
Insulin lispro |
Sanofi Winthrop Industrie |
— |
| Insuman Basal 100 IU/ml suspension for injection in a cartridge EU/1/97/030/035 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Basal 100 IU/ml suspension for injection in a cartridge EU/1/97/030/057 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Basal 100 IU/ml suspension for injection in a cartridge EU/1/97/030/058 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Basal 100 IU/ml suspension for injection in a vial EU/1/97/030/033 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Basal 100 IU/ml suspension for injection in a vial EU/1/97/030/034 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Basal 40 IU/ml suspension for injection in a vial EU/1/97/030/036 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Basal 40 IU/ml suspension for injection in a vial EU/1/97/030/037 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Comb 15 100 IU/ml suspension for injection in a cartridge EU/1/97/030/040 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Comb 15 100 IU/ml suspension for injection in a cartridge EU/1/97/030/059 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Comb 15 100 IU/ml suspension for injection in a cartridge EU/1/97/030/060 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Comb 15 100 IU/ml suspension for injection in a vial EU/1/97/030/038 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Comb 15 100 IU/ml suspension for injection in a vial EU/1/97/030/039 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |